News

Demant provided 2025 guidance, projecting organic revenue growth of 3%-7% and EBIT before special items in the range of ...
Investing.com -- Shares of Demant A/S (CSE:DEMANT) fell 5.5% as the company reported a soft revenue dynamic, despite a 4% ...
Demant's Kind acquisition is seen by analysts as part of a broader turnaround, with the Danish company regaining ground through new products, U.S. re-entry and French market renewal, just as Swish ...
Narrow-moat Demant DEMANT announced that the U.K. Competition and Markets Authority’s provisional finding (prior to the final report in early June) is that the divestment of Oticon Medical to ...
Investing.com -- Bernstein has upgraded Demant (CSE: DEMANT) to “outperform” from “market-perform,” citing improving growth drivers and reduced downside risks, in a note dated Friday. The brokerage ...
On Thursday, Citi analysts upgraded Demant A/S (DEMANT:DC) (OTC: WILYY) stock from Neutral to Buy, citing expectations for significant growth in wholesale organic sales growth (OSG) through the rest ...
Kepler Capital analyst Maja Pataki maintained a Hold rating on Demant (WILLF – Research Report) on April 22 and set a price target of DKK240.00. The company’s shares closed last Monday at $34. ...
COPENHAGEN, Nov 7 (Reuters) - Danish hearing aid maker Demant DEMANT.CO on Tuesday reported revenue for the third quarter broadly in line with expectations and narrowed its full-year outlook ...
Demant provided 2025 guidance, projecting organic revenue growth of 3%-7% and EBIT before special items in the range of DKK4.5 billion to DKK4.9 billion.